Observational Study to Evaluate Safety of Idarucizumab in Pediatric Patients

NCT02798107 · clinicaltrials.gov ↗
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped No recruitment

Conditions

Interventions

Sponsor

Boehringer Ingelheim